These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7913384)

  • 1. Why not octreotide?
    Mercadante S
    Support Care Cancer; 1994 May; 2(3):205-6. PubMed ID: 7913384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin Analogues in Neuroendocrine Tumors.
    Kulke MH
    J Natl Compr Canc Netw; 2016 Mar; 14(3):241-2. PubMed ID: 26957610
    [No Abstract]   [Full Text] [Related]  

  • 4. Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly.
    Giusti M; Sessarego P; Timossi G; Bocca L
    Eur J Endocrinol; 2000 Jun; 142(6):697-8. PubMed ID: 10822235
    [No Abstract]   [Full Text] [Related]  

  • 5. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients.
    Mercadante S; Maddaloni S
    J Pain Symptom Manage; 1992 Nov; 7(8):496-8. PubMed ID: 1283750
    [No Abstract]   [Full Text] [Related]  

  • 6. The palliative effects of octreotide in malignant disease.
    Dean A; Bridge D; Lickiss JN
    Ann Acad Med Singap; 1994 Mar; 23(2):212-5. PubMed ID: 7521613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide may prevent definitive intestinal obstruction.
    Mercadante S; Kargar J; Nicolosi G
    J Pain Symptom Manage; 1997 Jun; 13(6):352-5. PubMed ID: 9204656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide prevents the pathological alterations of bowel obstruction in cancer patients.
    Mercadante S; Avola G; Maddaloni S; Salamone G; Aragona F; Rodolico V
    Support Care Cancer; 1996 Sep; 4(5):393-4. PubMed ID: 8883235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment with octreotide for functional obstructions in scleroderma].
    Emmerich J; Roux ME; Capron L; Fiessinger JN
    Presse Med; 1992 Feb; 21(7):316-7. PubMed ID: 1532651
    [No Abstract]   [Full Text] [Related]  

  • 10. Octreotide in malignant intestinal obstruction.
    Pandha HS; Waxman J
    Anticancer Drugs; 1996 Jan; 7 Suppl 1():5-10. PubMed ID: 8822079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cases in the Management of NETs: Focus on Sequencing Somatostatin Analogs.
    Iyer R
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):4-7. PubMed ID: 27167991
    [No Abstract]   [Full Text] [Related]  

  • 12. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide.
    Murphy E; Prommer EE; Mihalyo M; Wilcock A
    J Pain Symptom Manage; 2010 Jul; 40(1):142-8. PubMed ID: 21634046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of preparations--analogues of somatostatin in surgical pancreatology].
    Kopchak VM; Kostylev MV; Kopchak KV; Egorova ON; Khomiak IV; Duvalko AV; Romaniv IaV; Pererva LA
    Klin Khir; 2008 Jan; (1):18-21. PubMed ID: 18610850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliation of malignant intestinal obstruction using octreotide.
    Khoo D; Hall E; Motson R; Riley J; Denman K; Waxman J
    Eur J Cancer; 1994; 30A(1):28-30. PubMed ID: 7511400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide for malignant bowel obstruction: twenty years after.
    Mercadante S; Porzio G
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the carcinoid syndrome with somatostatin, salmon calcitonin, or octreotide.
    Antonelli A; Gambuzza C; Bertoni F; Baschieri L
    Clin Ther; 1992; 14(2):178-84. PubMed ID: 1377097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.
    Altschul M; Simpson KW; Dykes NL; Mauldin EA; Reubi JC; Cummings JF
    J Small Anim Pract; 1997 Jul; 38(7):286-91. PubMed ID: 9239629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Somatostatin analogs-How we choose, and why.
    Reidy-Lagunes D; Raj N; Saltz L
    Semin Oncol; 2017 Apr; 44(2):157-158. PubMed ID: 28923214
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease.
    Krassas GE; Doumas A; Kaltsas T; Halkias A; Pontikides N
    Thyroid; 1999 Jan; 9(1):47-52. PubMed ID: 10037076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.